Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients
Zhi‐Yuan Zhou(Tsinghua University), Mingzhi Zhang(Chinese Academy of Sciences), Changying Chen(Center for Global Health), Beibei Qin(First Affiliated Hospital of Zhengzhou University), Xinhua Wang(Zhengzhou University), Xiaoli Li(Hubei University of Arts and Science), Lei Zhang(Union Hospital), Lisha Lu(First Affiliated Hospital of Zhengzhou University), Wang Ma(First Affiliated Hospital of Zhengzhou University), Xiang Li(First Affiliated Hospital of Zhengzhou University), Jianguo Wen(Argonne National Laboratory), Xin Li(Harbin Medical University), Jingjing Wu(Beijing Tian Tan Hospital), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University)
Cited by 52
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
|Cancer Cell|2018|251
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study
|The Lancet Infectious Diseases|2015|231
Altermagnets as a new class of functional materials
|Nature Reviews Materials|2025|200